Targeting LSD1 rewires kinase networks and primes leukaemia cells for kinase inhibitor treatment
Ontology highlight
ABSTRACT: We show that intrinsic resistance to kinase inhibitors may be reversed by coercing kinase networks into acquiring topologies tolerant to drug sensitivity. Using acute myeloid leukaemia (AML) as a model, we found several antagonists of chromatin modifying enzymes that sensitised cancer cells to kinase inhibitor treatments.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Myeloblast, Peripheral Blood
DISEASE(S): Acute Myeloid Leukemia
SUBMITTER:
Maruan Hijazi
LAB HEAD: Pedro Cutillas
PROVIDER: PXD018603 | Pride | 2022-04-25
REPOSITORIES: Pride
ACCESS DATA